Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage

References

• Zalev AH, Gardiner GW, Warren RE. NSAID injury to the small intestine. Abdom Imaging 1998;23:40–4.
   PubMed Web of Science ®Google Scholar
• Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986;104:390–8.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;2:1171–4.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, Levi S, Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987;2:711–4.
   PubMed Web of Science ®Google Scholar
• Meling TR, Aabakken L, Roseth A, Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996;31:339–44.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362–6.
   PubMed Web of Science ®Google Scholar
• Montalto M, Curigliano V, Santoro L, Lombardi M, Covino M, Cammarota G, Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. Eur J Gastroenterol Hepatol 2006;18:965–7.
   PubMed Web of Science ®Google Scholar
• Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998;43:506–11.
   PubMed Web of Science ®Google Scholar
• Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 2008;43:581–8.
   PubMed Web of Science ®Google Scholar
• Qvigstad G, Hatlen-Rebhan P, Brenna E, Waldum HL. Capsule endoscopy in clinical routine in patients with suspected disease of the small intestine: a 2-year prospective study. Scand J Gastroenterol 2006;41:614–8.
   PubMed Web of Science ®Google Scholar
• Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008;43:270–6.
   PubMed Web of Science ®Google Scholar
• Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T, Mizushima T. Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 2000;45:1674–9.
   PubMed Web of Science ®Google Scholar
• Dekigai H, Nakamura H, Bai J, Tanito M, Masutani H, Hirota K, Geranylgeranylacetone promotes induction and secretion of thioredoxin in gastric mucosal cells and peripheral blood lymphocytes. Free Radic Res 2001;35:23–30.
   PubMed Web of Science ®Google Scholar
• Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996;111:345–57.
   PubMed Web of Science ®Google Scholar
• Oketani K, Murakami M, Fujisaki H, Wakabayashi T, Hotta K. Effect of geranylgeranylacetone on aspirin-induced changes in gastric glycoproteins. Jpn J Pharmacol 1983;33:593–601.
   PubMedGoogle Scholar
• Tanaka K, Tsutsumi S, Arai Y, Hoshino T, Suzuki K, Takaki E, Genetic evidence for a protective role of heat shock factor 1 against irritant-induced gastric lesions. Mol Pharmacol 2007;71:985–93.
   PubMed Web of Science ®Google Scholar
• Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986;33:206–10.
   PubMed Web of Science ®Google Scholar
• Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol 2006;41:562–8.
   PubMedGoogle Scholar
• Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55–9.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Aisenberg J, Bhadra P, Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007;25:1211–22.
   PubMed Web of Science ®Google Scholar
• Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007;5:1040–5.
   PubMed Web of Science ®Google Scholar
• Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009;79:44–51.
   PubMed Web of Science ®Google Scholar
• Endo H, Hosono K, Inamori M, Nozaki Y, Yoneda K, Fujita K, Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol 2009;44:544–9.
   PubMed Web of Science ®Google Scholar
• Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H, Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009;7:524–9.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008;6:1279–82.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3:133–41.
   PubMed Web of Science ®Google Scholar
• Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005;128:1172–8.
   PubMed Web of Science ®Google Scholar
• Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:85–6.
   PubMed Web of Science ®Google Scholar
• van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996;72 Suppl 2:S39–48; discussion S49–51.
   PubMedGoogle Scholar
• Alberts MJ, Bergman DL, Molner E, Jovanovic BD, Ushiwata I, Teruya J. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke 2004;35:175–8.
   PubMed Web of Science ®Google Scholar
• Brandon RA, Emmett JA, Eadie MJ, Curran AC, Bunce IH. Peripheral venous plasma aspirin concentrations and platelet aggregation inhibition produced by enteric-coated aspirin formulations. Thromb Haemost 1986;55:222–7.
   PubMedGoogle Scholar
• Wilcox GM, Mattia A. Collagenous colitis associated with lansoprazole. J Clin Gastroenterol 2002;34:164–6.
   PubMed Web of Science ®Google Scholar
• Sakamoto C, Ogoshi K, Saigenji K, Narisawa R, Nagura H, Mine T, Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: a randomized, double-blind trial in Japan. Digestion 2007;75:215–24.
   PubMedGoogle Scholar
• Arakawa T, Higuchi K, Fujiwara Y, Watanabe T, Tominaga K, Sasaki E, 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 2005;50 Suppl 1:S3–11.
   PubMedGoogle Scholar
• Mizoguchi H, Ogawa Y, Kanatsu K, Tanaka A, Kato S, Takeuchi K. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroenterol Hepatol 2001;16:1112–9.
   PubMed Web of Science ®Google Scholar